Integral Diagnostics Limited (ASX:IDX)

Integral Diagnostics Revenue

Integral Diagnostics had revenue of 393.48M AUD in the half year ending December 31, 2025, with 70.15% growth. This brings the company's revenue in the last twelve months to 767.82M, up 56.28% year-over-year. In the fiscal year ending June 30, 2025, Integral Diagnostics had annual revenue of 627.22M with 33.54% growth.

• Revenue (ttm): 767.82M
• Revenue Growth: +56.28%
• P/S Ratio: 1.00
• Revenue / Employee: 255.94K
• Employees: 3,000
• Market Cap: 771.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	627.22M	157.52M	33.54%
Jun 30, 2024	469.70M	28.94M	6.56%
Jun 30, 2023	440.76M	79.83M	22.12%
Jun 30, 2022	360.93M	10.23M	2.92%
Jun 30, 2021	350.70M	75.13M	27.26%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 6, 2026

Data Sources Report a data error